Neutral
Cornerstone Investment Partners LLC trimmed its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 1.3% in the 4th quarter, according to th...
A judge has dismissed Elevance Health's lawsuit challenging Medicare Advantage ratings. This decision prevents the insurer from forcing a review of it...
Bullish
Barclays has increased its price target for Elevance Health (ELV) to $408 from $393, while reiterating an Overweight rating on the stock. This adjustm...
Elevance Health, Inc. published its Q1 2026 earnings call presentation, reporting an EPS of $12.58, beating estimates by $1.77, and revenue of $49.49 ...
Bullish
Google's 2026 Discover Core Update is revolutionizing how investors access news for companies like Elevance Health Inc, prioritizing mobile-first, per...
Bearish
Kirby McInerney LLP is investigating potential claims against Elevance Health, Inc. (NYSE:ELV) following a disclosure by Elevance that the Centers for...
Bullish
Elevance Health is undergoing a multi-year re-rating opportunity as the U.S. healthcare system shifts towards an integrated, value-based structure. Wh...